Biotech ETFs can help investors capitalize on health care innovation while avoiding the boom-or-bust nature of individual ...

Graymark bought the Atrium Labs site in Emeryville for $26.9M, a steep discount that underlines the Bay Area lab glut.

A cross-section of biotech leaders is launching the American Biotech Innovation Alliance (ABIA) with the goal of uniting ...

Biotech stock Avalo Therapeutics skyrocketed to a two-year high Wednesday on positive results for its skin disease treatment.

Corcept Therapeutics Inc. (NASDAQ: CORT) is one of the 10 best biotech stocks with highest upside potential.

Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce risk in a volatile sector.

The biotech group has struggled as a whole in 2025, but analysts say the innovation that has always supported the biotech ...

This Biotech Stock Is Down 65%. How a Cancer Trial Was Ruined by Its Own Design. Compass Therapeutics says a treatment evaluating its cancer treatment didn’t meet the secondary endpoint for an ...

Blackstone Inc. is investing $250 million in the biotech startup Anagram Therapeutics Inc., part of the private equity giant’s strategy to own more cutting-edge drugmakers.

The biggest biotech deal so far in 2026 was announced in April. Pacts were signed over ADCs, small molecules, and AI ...

By Marleen Kaesebier BASEL, Switzerland, May 5 (Reuters) - Switzerland's biotech industry shifted toward private financing in 2025 as funding from capital markets remained difficult to obtain and ...